Eastern Isotopes expands PET network through acquisition

Eastern Isotopes Inc. has made a move to expand its PET (positron emission tomography) tracer production and distribution network through the acquisition of Pharmalogic LLC, with its facilities, which include cyclotrons, located in New York, Massachusetts, and New Jersey.
   
The acquisition has been made through Eastern Isotopes' parent company IBA (Ion Beam Applications S.A.) based in Europe. The move is part of the company's overall global network strategy and also to give a boost to U.S. distribution channels.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.